Version 5.4
Mus musculus Protein: Slc41a3
Summary
InnateDB Protein IDBP-169170.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol Slc41a3
Protein Name solute carrier family 41, member 3
Synonyms 1010001P06Rik; AI480742; SLC41A1-L2;
Species Mus musculus
Ensembl Protein ENSMUSP00000032177
InnateDB Gene IDBG-169166 (Slc41a3)
Protein Structure
UniProt Annotation
Function
Subcellular Localization Cell membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 2 experimentally validated interaction(s) in this database.
They are also associated with 3 interaction(s) predicted by orthology.
Experimentally validated
Total 2 [view]
Protein-Protein 1 [view]
Protein-DNA 1 [view]
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 3 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0008324 cation transmembrane transporter activity
Biological Process
GO:0006812 cation transport
GO:0008150 biological_process
Cellular Component
GO:0005886 plasma membrane
GO:0016021 integral component of membrane
Protein Structure and Domains
PDB ID MGI:1918949
InterPro IPR006667 SLC41 divalent cation transporters, integral membrane domain
PFAM PF01769
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q921R8
PhosphoSite PhosphoSite-
TrEMBL
UniProt Splice Variant
Entrez Gene 71699
UniGene Mm.272633
RefSeq NP_001032570
MGI ID
MGI Symbol Slc41a3
OMIM
CCDS CCDS20363
HPRD
IMGT
EMBL AK003140 BC011108
GenPept AAH11108 BAB22598

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca